Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Mayo Clinic
Mayo Clinic
SWOG Cancer Research Network
Academic and Community Cancer Research United
National Institutes of Health Clinical Center (CC)
Fondazione Italiana Linfomi - ETS
Novartis
French Innovative Leukemia Organisation
Nanfang Hospital, Southern Medical University
University of Minnesota